Exploratory Time-Dependent Patterns in Estimated Treatment Effect of Talazoparib Plus Enzalutamide in HRR Non-Deficient or Unknown Metastatic Castration-Resistant Prostate Cancer: A Post Hoc Analysis of the TALAPRO-2 Trial.

enzalutamide - Generic mfg.

Talzenna (talazoparib) - Pfizer

http://www.ncbi.nlm.nih.gov/pubmed/42502892

Akihiro Hirakawa; Hajime Tanaka; Hiroshi Fukushima; Hiroyuki Sato; Hitoshi Masuda; Shugo Yajima; Soichiro Yoshida; Wei Chen; Yasuhisa Fujii

Jul 27, 2026